세계의 지팡이 및 목발 시장 - 규모, 점유율, 동향 분석 보고서 : 제품별, 유통 채널별, 지역별, 부문 예측(2024-2030년)

Canes And Crutches Market Size, Share & Trends Analysis Report By Product (Canes, Crutches, Accessories), By Distribution Channel (Hospital Pharmacies, Medical Retail Stores, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,163,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,536,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,280,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

지팡이 및 목발 시장의 성장과 동향 :

Grand View Research, Inc의 최신 보고서에 따르면 지팡이 및 목발 세계 시장 규모는 2024-2030년에 걸쳐 4.9%의 연평균 복합 성장률(CAGR)을 기록하며 2030년에는 14억 9,000만 달러에 이를 전망입니다.

시장 성장을 가속하는 주요 요인으로는 자동차 충돌 사고, 골관절염, 장애 증가, 노인 인구 증가, 정부 활동 등이 있습니다. 2023년 8월에 발표된 워싱턴 대학의 논문에 따르면, 변형성 관절증은 2020년에 세계에서 5억 9,500만 명이 이환되었으며, 이는 세계 인구의 7.6%에 해당합니다. 예측은 2050년까지 상당한 증가가 예상되고, 변형성 무릎 관절증에서는 74.9%, 기타 변형성 관절증에서는 95.1% 증가가 예측되고 있습니다.

게다가 장애 사례 증가는 시장 성장을 뒷받침하고 있습니다. WHO가 2023년 3월 발표한 논문에 따르면 세계 전체에서 약 13억명이 중대한 장애를 안고 생활하고 있으며 이는 세계 인구의 16%를 차지합니다. 이는 전 세계적으로 장애가 광범위하게 영향을 미치고 있음을 강조하고 전 세계 장애인의 접근성과 지원을 개선하기 위한 지속적인 노력의 필요성을 강조합니다. 이동 보조기구의 진보는 또한 시장의 성장을 뒷받침하고 있습니다.

시각 장애인을 위한 새로운 지팡이 기술은 장애물을 감지하는 센서와 소나를 통합하여 충전 가능, 내구성 및 범용 설치 기능을 설명합니다. MAVI와 같은 프로젝트는 OCR을 통해 보행자와 텍스트를 포함한 장애물을 감지하고 설명하기 위해 이러한 지팡이를 강화하는 것을 목표로합니다. 또한, 목발의 디자인은 무거운 목제 모델에서 알루미늄, 티타늄, 탄소섬유 등의 재료를 사용한 경량 버전으로 진화하고 있습니다. 최신의 목발는 인체공학에 근거한 디자인, 윤곽이 있는 암 패드, 개량된 첨단, 강화된 가동 영역을 특징으로 하여, 2차적인 부상을 줄여, 유저의 쾌적함과 이동성을 향상 있습니다.

지팡이 및 목발 시장 보고서 하이라이트

• 지팡이 부문은 지속적인 제품 진보, 주요 기업의 이니셔티브 확대, 제품 채용 증가로 2023년에는 52.07% 이상의 최대 점유율을 차지했습니다. 접이식, 네 개의 접이식, 오프셋식 등 지팡이의 최근 발전은 신재료와 인체공학적 특성을 통해 편안함, 기능성, 적응성을 높이는 데 중점을 둡니다.
• 병원 약국 부문은 2023년 43.19%의 최대 점유율을 차지했습니다. 의료 시설의 경우 병원은 이러한 이동 보조 장비를 조달하기 위한 중심지가 되는 중요한 기지입니다.
• 북미는 유리한 상환 정책, 고급 의료 인프라, 고령화 인구 증가, 관절염 증례 수 증가, 신속한 규제 당국 승인, 신제품 출시 등으로 2023년 36.0% 점유율로 시장을 독점했습니다.
• 아시아태평양시장은 만성질환 유병률 상승과 교통사고 다발로 인해 2024-2030년에 걸쳐 가장 빠른 CAGR 6.2%를 나타낼 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 지팡이 및 목발 시장의 변수, 동향, 범위

• 시장 계통의 전망
  • 모 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 지팡이 및 목발 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 지팡이 및 목발 시장 :제품, 추정·동향 분석

• 지팡이 및 목발 시장 :제품 대시보드
• 지팡이 및 목발 시장 : 제품 변동 분석
• 지팡이 및 목발 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
• 지팡이
• 목발
• 액세서리

제5장 지팡이 및 목발 시장 : 유통 채널, 추정·동향 분석

• 지팡이 및 목발 시장 : 유통 채널 대시보드
• 지팡이 및 목발 시장 : 유통 채널 변동 분석
• 지팡이 및 목발 시장 규모와 예측과 동향 분석, 유통 채널별, 2018-2030년
• 병원 약국
• 의료 소매점
• 온라인 약국

제6장 지팡이 및 목발 시장 :국가, 제품, 유통 채널별 지역 추정·동향 분석

• 세계의 지팡이 및 목발 시장 :지역별 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제7장 경쟁 구도

• 기업/경쟁의 분류
• 기업의 시장 포지셔닝 분석
  • 주요 기업의 시장 점유율 분석, 2023년
  • 히트맵 분석
• 기업 프로파일
  • Drive DeVilbiss Healthcare
  • Ossenberg GmbH
  • Ergoactives
  • NOVA Medical Products
  • GF Health Products Inc
  • Sunrise Medical Limited
  • Besco Medical Co., Ltd
  • Invacare Corporation
  • Medline Industries, Inc
  • Cardinal Health, Inc

JHS

영문 목차

영문목차

Canes And Crutches Market Growth & Trends:

The global canes and crutches market size is expected to reach USD 1.49 billion by 2030, registering a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market growth include the rising cases of vehicle collisions, osteoarthritis, & disabilities, growing geriatric population, and government initiatives. According to a University of Washington article published in August 2023, osteoarthritis affected 595 million people globally in 2020, equivalent to 7.6% of the global population. Projections suggest substantial growth by 2050, with anticipated rises of 74.9% for knee osteoarthritis and 95.1% for other forms of osteoarthritis across different joints.

Moreover, the increasing number of disability cases fuels the market's growth. According to the WHO article published in March 2023, about 1.3 billion individuals globally live with significant disabilities, accounting for 16% of the world's population, which translates to roughly 1 in every 6 people. This underscores the widespread impact of disabilities on a global scale, highlighting the need for continued efforts to improve accessibility and support for people with disabilities worldwide. Advancements in mobility aids are also driving market growth.

New cane technologies for individuals with visual impairments integrate sensors and sonars to detect obstacles, offering rechargeability, durability, and universal mounting capabilities. Projects like MAVI aim to enhance these canes to detect and describe obstacles, including pedestrians and text through OCR. Moreover, crutch design has evolved from heavy wooden models to lightweight versions made of materials like aluminum, titanium, and carbon fiber. Modern crutches feature ergonomic designs, contoured arm pads, improved tips, and enhanced range of motion, reducing secondary injuries and improving user comfort and mobility.

Canes And Crutches Market Report Highlights:

• The canes segment held the largest share of over 52.07% in 2023 due to ongoing product advancements, growing initiatives by key companies, and increasing product adoption. Recent advancements in canes, including folding, quad, and offset designs, focus on enhancing comfort, functionality, and adaptability through new materials and ergonomic features
• The hospital pharmacies segment held the largest share of 43.19% in 2023. Hospitals are crucial centers for providing a central point for healthcare facilities to procure these mobility aids
• North America dominated the market with a share of 36.0% in 2023 owing to favorable reimbursement policies, advanced healthcare infrastructure, a growing aging population, an increasing number of arthritis cases, quick regulatory approvals, and new product launches
• The market in Asia Pacific is projected to register the fastest CAGR of 6.2% from 2024 to 2030 owing to a rise in the prevalence of chronic illnesses and the high frequency of road accidents

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Distribution Channel
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecast timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity price analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Segment
  • 2.2.2. Distribution Channel Segment
• 2.3. Competitive Insights

Chapter 3. Global Canes and crutches Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rise in musculoskeletal conditions
    • 3.2.1.2. Increasing number of vehicle collisions
    • 3.2.1.3. Growing number of people with disabilities
    • 3.2.1.4. Advancements in materials and design
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent Regulatory Policies
    • 3.2.2.2. Social Stigma Associated with Utilization of Canes and Crutches
• 3.3. Canes and Crutches Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Canes and crutches Market: Product Estimates & Trend Analysis

• 4.1. Canes and crutches Market: Product Dashboard
• 4.2. Canes and crutches Market: Product Movement Analysis
• 4.3. Canes and crutches Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Canes
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.2. Folding Canes
    • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.3. Quad Canes
    • 4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.4.4. Offset Canes
    • 4.4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Crutches
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Axillary Crutches
    • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.3. Forearm Crutches
    • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Accessories
  • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Canes and crutches Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Canes and crutches Market: Distribution Channel Dashboard
• 5.2. Canes and crutches Market: Distribution Channel Movement Analysis
• 5.3. Canes and crutches Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 5.4. Hospital Pharmacies
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Medical Retail Stores
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.6. Online Pharmacies
  • 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Canes and crutches Market: Regional Estimates & Trend Analysis by Country, Product, Distribution Channel, & Distribution Channel

• 6.1. Global Canes and crutches Market: Regional Dashboard
• 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
• 6.3. North America
  • 6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.3.2. U.S.
    • 6.3.2.1. Key country dynamics
    • 6.3.2.2. Regulatory framework/ reimbursement structure
    • 6.3.2.3. Competitive scenario
    • 6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key country dynamics
    • 6.3.3.2. Regulatory framework/ reimbursement structure
    • 6.3.3.3. Competitive scenario
    • 6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key country dynamics
    • 6.3.4.2. Regulatory framework/ reimbursement structure
    • 6.3.4.3. Competitive scenario
    • 6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• 6.4. Europe
  • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework/ reimbursement structure
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework/ reimbursement structure
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key country dynamics
    • 6.4.4.2. Regulatory framework/ reimbursement structure
    • 6.4.4.3. Competitive scenario
    • 6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key country dynamics
    • 6.4.5.2. Regulatory framework/ reimbursement structure
    • 6.4.5.3. Competitive scenario
    • 6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key country dynamics
    • 6.4.6.2. Regulatory framework/ reimbursement structure
    • 6.4.6.3. Competitive scenario
    • 6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.7. Sweden
    • 6.4.7.1. Key country dynamics
    • 6.4.7.2. Regulatory framework/ reimbursement structure
    • 6.4.7.3. Competitive scenario
    • 6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.8. Norway
    • 6.4.8.1. Key country dynamics
    • 6.4.8.2. Regulatory framework/ reimbursement structure
    • 6.4.8.3. Competitive scenario
    • 6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4.9. Denmark
    • 6.4.9.1. Key country dynamics
    • 6.4.9.2. Regulatory framework/ reimbursement structure
    • 6.4.9.3. Competitive scenario
    • 6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5.2. China
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework/ reimbursement structure
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.3. Japan
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework/ reimbursement structure
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework/ reimbursement structure
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework/ reimbursement structure
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework/ reimbursement structure
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework/ reimbursement structure
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Latin America
  • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework/ reimbursement structure
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework/ reimbursement structure
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. MEA
  • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Saudi Arabia
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework/ reimbursement structure
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.3. South Africa
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework/ reimbursement structure
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.4. UAE
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework/ reimbursement structure
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework/ reimbursement structure
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Company Market Position Analysis
  • 7.2.1. Key Company Market Share Analysis, 2023
  • 7.2.2. Heat Map Analysis
• 7.3. Company Profiles
  • 7.3.1. Drive DeVilbiss Healthcare
    • 7.3.1.1. Company overview
    • 7.3.1.2. Financial performance
    • 7.3.1.3. Product benchmarking
    • 7.3.1.4. Strategic initiatives
  • 7.3.2. Ossenberg GmbH
    • 7.3.2.1. Company overview
    • 7.3.2.2. Financial performance
    • 7.3.2.3. Product benchmarking
    • 7.3.2.4. Strategic initiatives
  • 7.3.3. Ergoactives
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. NOVA Medical Products
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. GF Health Products Inc
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Sunrise Medical Limited
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. Besco Medical Co., Ltd
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Invacare Corporation
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Medline Industries, Inc
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Cardinal Health, Inc
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives

관련자료